You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

autoantibody

Showing 1 - 25 of 397
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Amyotrophic Lateral Sclerosis, Plasmapheresis Trial (Plasmapheresis)

Not yet recruiting
  • Amyotrophic Lateral Sclerosis
  • Plasmapheresis
  • Plasmapheresis
  • (no location specified)
Oct 3, 2022

Mycobacterium Abscessus Infection in Chronic Lung Disease and

Enrolling by invitation
  • Mycobacterium Abscessus Infection
  • +2 more
  • Appropriate treatment
  • Pathum Wan, Bangkok, Thailand
    King Chulalongkorn Memorial Hospital
Aug 31, 2022

Autoimmune Diseases, Lupus Erythematosus, Systemic, Communicable Diseases Trial in Atlanta

Enrolling by invitation
  • Autoimmune Diseases
  • +2 more
    • Atlanta, Georgia
    • +2 more
    May 17, 2022

    Cardiomyopathy, Dilated, Heart Failure, Autoantibodies Trial in Belgrade, Belgrad (BC 007)

    Active, not recruiting
    • Cardiomyopathy, Dilated
    • +2 more
    • BC 007
    • Belgrade, Serbia
    • +2 more
    Jul 19, 2022

    Idiopathic Pulmonary Fibrosis, Acute Fatal Form Trial in United States (Autoantibody Reductive Therapy, Treatment as Usual

    Recruiting
    • Idiopathic Pulmonary Fibrosis, Acute Fatal Form
    • Autoantibody Reductive Therapy
    • Treatment as Usual (TAU)
    • Birmingham, Alabama
    • +6 more
    Sep 5, 2022

    The Specificity, Sensitivity and Clinical Correlation of CBA,

    Completed
    • Detection Autoantibody of Myasthenia Gravis
    • CBA Assay
    • Beijing, China
    • +1 more
    Jan 17, 2023

    Lupus Nephritis, Immunoglobulin A Nephropathy, Membranous Nephropathy Trial (povetacicept)

    Not yet recruiting
    • Lupus Nephritis
    • +2 more
    • (no location specified)
    Feb 16, 2023

    Ambulatory IPF Trial in United States (Rituximab, Placebo)

    Completed
    Has Results
    • Ambulatory IPF
    • Birmingham, Alabama
    • +6 more
    Jan 20, 2022

    Long Covid Trial in Berlin, Cologne, Münster (BC 007 or matching )

    Recruiting
    • Long Covid
    • BC 007 or matching placebo
    • Berlin, Germany
    • +3 more
    Jun 16, 2023

    MuSK Myasthenia Gravis Trial (MuSK-CAART)

    Not yet recruiting
    • MuSK Myasthenia Gravis
    • MuSK-CAART
    • (no location specified)
    Jul 5, 2022

    Tear Fluid and Blood for Auto Antibodies Produced in Response to

    Completed
    • SARS-CoV 2 Infection
    • Covid19
    • SARS-CoV2 Autoantibody detection
    • Fayetteville, Arkansas
      Namida Lab
    Mar 7, 2022

    Diabetes, Type 1 Trial in Dresden, München (intranasal insulin, Placebo)

    Completed
    • Diabetes Mellitus, Type 1
    • intranasal insulin
    • Placebo
    • Dresden, Germany
    • +1 more
    Jun 21, 2021

    Congenital Heart Block, Neonatal Lupus, Autoantibody-Associated Heart Block Trial in New York (Hydroxychloroquine)

    Completed
    Has Results
    • Congenital Heart Block
    • +2 more
    • New York, New York
      New York University School of Medicine
    Feb 4, 2021

    Clinical Performance of BioCLIA Ro60

    Withdrawn
    • Systemic Lupus Erythematosus
    • Sjogren's Syndrome
    • BioCLIA Ro60
    • Irvine, California
      CRM Biotech
    Aug 1, 2020

    Autoantigens in EGPA and Severe Eosinophilic Asthma

    Recruiting
    • Churg-Strauss Syndrome
    • +3 more
    • Autoantibody ELISA
    • London, United Kingdom
    • +1 more
    Dec 10, 2020

    Early Cancer Detection Test - Lung Cancer China

    Unknown status
    • Lung Cancer
    • Tumor autoantibody detection
    • Shanghai, Shanghai, China
    • +2 more
    Dec 31, 2019

    Type1 Diabetes Trial (Oral glucose tolerance test (OGTT), Hyperglycemic clamp test, Continuous glucose monitoring)

    Not yet recruiting
    • Type1 Diabetes Mellitus
    • Oral glucose tolerance test (OGTT)
    • +2 more
    • (no location specified)
    Mar 8, 2023

    Bullous Pemphigoid Trial in Worldwide (dupilumab, Matching Placebo, Oral corticosteroids (OCS))

    Recruiting
    • Bullous Pemphigoid
    • Scottsdale, Arizona
    • +50 more
    Jan 13, 2023

    PRenatal and Obstetric Maternal Exposures and ISlet

    Recruiting
    • Type 1 Diabetes
    • Pregnancy in Diabetic
      • Aurora, Colorado
      • +3 more
      Nov 15, 2023

      Immunotherapy, ADR Trial in Beijing

      Not yet recruiting
      • Immunotherapy
      • ADR
        • Beijing, Beijing, China
          Xuanwu Hospital
        Jan 27, 2023

        Commercial Assay for the Detection of Neuronal Antibodies

        Completed
        • Paraneoplastic Neurological Syndrome
        • Autoimmune Encephalitis
        • Indirect immunofluorescence assay on tissue slides and cell-based assays with CSF and/or sera
        • Bron, France
        • +1 more
        Mar 13, 2023

        Systemic Lupus Erythematosus Trial in Worldwide (BENLYSTA, SLE treatment)

        Active, not recruiting
        • Systemic Lupus Erythematosus
        • BENLYSTA
        • SLE treatment
        • Birmingham, Alabama
        • +177 more
        Jan 23, 2023

        Evolution of Pre Type 1 Diabetes With Adult ONset

        Active, not recruiting
        • Type 1 Diabetes
        • Type 1 Diabetes Mellitus Maturity Onset
        • High genetic risk for type 1 diabetes
        • High gentic risk for Coeliac disease
        • Exeter, Devon, United Kingdom
          NIHR Exeter Clinical Research Facility (Royal Devon University H
        Aug 16, 2023

        Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Trial in Japan (Rituximab (genetical recombination), Placebo)

        Completed
        • Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
        • Rituximab (genetical recombination)
        • Placebo
        • Nagoya, Aich, Japan
        • +3 more
        Aug 19, 2021

        Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia,

        Recruiting
        • Autoimmune Hemolytic Anemia
        • +5 more
        • cytokine essays
        • +6 more
        • Milano, Italy
          Fondazione Irccs Ca' Granda Ospedale Maggiore Policlinico
        Jul 3, 2023